Education
About Us
Working with TipRanks
Follow Us
VITA 34 AG (DE:V3V)
XETRA:V3V
V3V Stock Chart & Stats
Day’s Range― - ―
52-Week Range€3.70 - €7.65
Previous CloseN/A
Volume271.00
Average Volume (3M)2.78K
Market Cap
€98.49M
Enterprise Value€85.60M
Total Cash (Recent Filing)€11.50M
Total Debt (Recent Filing)€19.67M
Price to Earnings (P/E)27.3
Beta0.19
Next Earnings
Nov 21, 2025EPS EstimateN/A
Last Dividend Ex-Date
Jun 05, 2019Dividend YieldN/A
Share Statistics
EPS (TTM)0.04
Shares Outstanding17,640,104
10 Day Avg. Volume1,695
30 Day Avg. Volume2,779
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€7.00Price Target Upside21.74% Upside
Rating ConsensusHold
Number of Analyst Covering0
V3V FAQ
What was VITA 34 AG’s price range in the past 12 months?
VITA 34 AG lowest stock price was €3.70 and its highest was €7.65 in the past 12 months.
What is VITA 34 AG’s market cap?
VITA 34 AG’s market cap is €98.49M.
When is VITA 34 AG’s upcoming earnings report date?
VITA 34 AG’s upcoming earnings report date is Nov 21, 2025 which is in 55 days.
How were VITA 34 AG’s earnings last quarter?
VITA 34 AG released its earnings results on Aug 27, 2025. The company reported €0.038 earnings per share for the quarter, beating the consensus estimate of N/A by €0.038.
Is VITA 34 AG overvalued?
According to Wall Street analysts VITA 34 AG’s price is currently Undervalued.
Does VITA 34 AG pay dividends?
VITA 34 AG pays a Annually dividend of €0.16 which represents an annual dividend yield of N/A. See more information on VITA 34 AG dividends here
What is VITA 34 AG’s EPS estimate?
VITA 34 AG’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does VITA 34 AG have?
VITA 34 AG has 17,640,104 shares outstanding.
What happened to VITA 34 AG’s price movement after its last earnings report?
VITA 34 AG reported an EPS of €0.038 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 12.403%.
Which hedge fund is a major shareholder of VITA 34 AG?
Currently, no hedge funds are holding shares in DE:V3V
VITA 34 Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
€7.00 (21.74% Upside)
€7.00 (21.74% Upside)
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
―
20 days / 200 days
Momentum
21.14%
12-Months-Change
Fundamentals
Return on Equity
-53.67%
Trailing 12-Months
Asset Growth
-0.15%
Trailing 12-Months
Company Description
VITA 34 AG
VITA 34 (V3V) is a leading company in the field of stem cell banking and regenerative medicine, specializing in the collection, processing, and storage of stem cells derived from umbilical cord blood and tissue. The company operates primarily in the healthcare sector, offering its services to expectant parents and healthcare providers. VITA 34's core products include private and public stem cell storage solutions, as well as related services that support the use of stem cells in medical treatments and research.
Technical Analysis
MATERNUS-Kliniken AG
―
Limes Schlosskliniken AG
―
HAEMATO AG
―
Gesundheitswelt Chiemgau AG
―
MPH Health Care AG
―